Clinical characteristics of MTS in 23 patients with XLA-MTS
| Symptoms . | Number of patients . | Median onset (years) . | References . |
|---|---|---|---|
| Hearing impairment | 18 (78%) | 3.5 | (33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45) |
| Speech delay/abnormality | 12 (52%) | 3 | (35, 37, 38, 39, 42) |
| Dystonia | 5 (22%) | 5 | (34, 36, 37, 44) |
| Psychological developmental disorder | 5 (22%) | 7 | (34, 37, 40, 42, 45) |
| Motor developmental delay | 3 (13%) | 3 | (37, 42) |
| Visual impairment | 3 (13%) | 15 | (34, 36, 41) |
| Intellectual disability | 2 (9%) | 17.5 | (34, 36) |
| Dysgraphia | 2 (9%) | 17.5 | (36, 45) |
| Symptoms . | Number of patients . | Median onset (years) . | References . |
|---|---|---|---|
| Hearing impairment | 18 (78%) | 3.5 | (33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45) |
| Speech delay/abnormality | 12 (52%) | 3 | (35, 37, 38, 39, 42) |
| Dystonia | 5 (22%) | 5 | (34, 36, 37, 44) |
| Psychological developmental disorder | 5 (22%) | 7 | (34, 37, 40, 42, 45) |
| Motor developmental delay | 3 (13%) | 3 | (37, 42) |
| Visual impairment | 3 (13%) | 15 | (34, 36, 41) |
| Intellectual disability | 2 (9%) | 17.5 | (34, 36) |
| Dysgraphia | 2 (9%) | 17.5 | (36, 45) |
XLA, X-linked agammaglobulinemia; MTS, Mohr–Tranebjaerg syndrome. Median onset is shown as years.